Next Century Growth Investors LLC Lowers Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Next Century Growth Investors LLC reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 35.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75,521 shares of the company's stock after selling 41,202 shares during the period. Next Century Growth Investors LLC owned about 0.09% of HealthEquity worth $7,246,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Arcadia Investment Management Corp MI acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC grew its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new position in HealthEquity in the fourth quarter valued at $39,000. UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ raised its position in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after acquiring an additional 445 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Analysts Set New Price Targets

HQY has been the subject of several recent analyst reports. The Goldman Sachs Group cut their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Barrington Research reiterated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. KeyCorp decreased their price objective on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Monday, March 24th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $112.58.

Remove Ads

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,381 shares of company stock worth $1,781,432. Insiders own 2.20% of the company's stock.

HealthEquity Trading Down 0.4 %

Shares of NASDAQ HQY traded down $0.33 during trading on Tuesday, hitting $83.03. 644,192 shares of the company were exchanged, compared to its average volume of 761,763. The company has a fifty day moving average price of $96.47 and a 200-day moving average price of $96.35. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $7.18 billion, a PE ratio of 76.17, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.